"Sorafenib" の関連情報検索結果

Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in ...



Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC  Pharmacy Times

Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular c...



Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma  Nature

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable...



Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial  The Lancet

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of fer...



CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis  Molecular Cancer

Targeted delivery of sorafenib via biotin decorated polyaminoaspartamide-based nanoparticles for ...



Targeted delivery of sorafenib via biotin decorated polyaminoaspartamide-based nanoparticles for the hepatocarcinoma treatment  ScienceDirect.com

Anlotinib/Penpulimab Enhances Survival vs Sorafenib in Unresectable HCC - CancerNetwork



Anlotinib/Penpulimab Enhances Survival vs Sorafenib in Unresectable HCC  CancerNetwork

Tribbles Pseudokinase 3 Converts Sorafenib Therapy to Neutrophil-Mediated Lung Metastasis in Hepa...



Tribbles Pseudokinase 3 Converts Sorafenib Therapy to Neutrophil-Mediated Lung Metastasis in Hepatocellular Carcinoma  Wiley

Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcin...



Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis  Frontiers

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment - Nature



Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment  Nature

Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspect...



Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects  ScienceDirect.com

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular...



Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial  The Lancet

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma b...



Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation  Molecular Cancer

PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocell...



PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma  Wiley

CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R...



CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loop  Nature

Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellula...



Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC  ScienceDirect.com

Combining Sorafenib, Se-methylselenocysteine, and α-Ketoacid for synergistic cytotoxicity in Hepa...



Combining Sorafenib, Se-methylselenocysteine, and α-Ketoacid for synergistic cytotoxicity in Hepatocellular carcinoma cell lines  ScienceDirect.com

Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepa...



Camel milk extracellular vesicles-mediated co-delivery of siVEGF/sorafenib enhances the anti-hepatocellular carcinoma activity by dual-effect blocking the biological effects of VEGF  ScienceDirect.com

Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects ...



Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects through synergistically potentiating ferroptosis and remodeling tumor immune microenvironment  ScienceDirect.com

Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinom...



Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma  ACS Publications

Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer c...



Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer cells  ScienceDirect.com

Systemic delivery of sorafenib tosylate loaded LeciPlex®: A comparative assessment of nano assemb...



Systemic delivery of sorafenib tosylate loaded LeciPlex®: A comparative assessment of nano assembly, biocompatibility, and In vivo drug disposition  ScienceDirect.com

Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocell...



Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial  The Lancet

Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network p...



Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation  Frontiers

Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs ...



Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs via overcoming the hypoxia tumor microenvironment  ScienceDirect.com

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular ...



GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma  ScienceDirect.com

Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafen...



Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment  ScienceDirect.com

NCOA5 induces sorafenib resistance in hepatocellular carcinoma by inhibiting ferroptosis | Cell D...



NCOA5 induces sorafenib resistance in hepatocellular carcinoma by inhibiting ferroptosis | Cell Death Discovery  Nature

Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients - News-Medical



Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients  News-Medical

How the chemotherapy drug sorafenib triggers muscle wasting through cell remodeling - Medical Xpress



How the chemotherapy drug sorafenib triggers muscle wasting through cell remodeling  Medical Xpress

Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53...



Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53 pathway  ScienceDirect.com

Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenog...



Phosphoproteomics profiling of sorafenib-resistant hepatocellular carcinoma patient-derived xenografts reveals potential therapeutic strategies  ScienceDirect.com

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectab...



Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectable hepatocellular carcinoma: a cost–utility analysis in China and the United States  Frontiers

TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating...



TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways  Nature

Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibi...



Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCs  ACS Publications

Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in li...



Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer  BMC Cancer

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoemboli...



Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma  Nature

Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcino...



Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcinoma and effects of Kanglaite Injection  ScienceDirect.com

Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocel...



Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation | Cell Death & Disease  Nature

Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepa...



Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepatocellular Carcinoma Activity  ACS Publications

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein ...



Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis  ScienceDirect.com

Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma V...



Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis  ACS Publications

Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepa...



Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepatocellular Carcinoma  ACS Publications

Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti...



Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy  Nature

TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NA...



TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma  Nature

Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nr...



Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway  ScienceDirect.com

From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis...



From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma  ScienceDirect.com

Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma:...



Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update  ScienceDirect.com

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for...



Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma  ScienceDirect.com

Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC - Molecular Cancer



Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC  Molecular Cancer

Autophagy modulation attenuates sorafenib resistance in HCC induced in rats - Nature



Autophagy modulation attenuates sorafenib resistance in HCC induced in rats  Nature

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therape...



The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects  Nature

Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines - Nature



Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines  Nature

Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cance...



Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells  Nature

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors - Nature



Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors  Nature

Sorafenib for Advanced and Refractory Desmoid Tumors - The New England Journal of Medicine



Sorafenib for Advanced and Refractory Desmoid Tumors  The New England Journal of Medicine

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 - Nature



CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1  Nature

Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepa...



Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis  ScienceDirect.com

Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma - Science...



Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma  ScienceDirect.com

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ...



Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis  Journal of Experimental & Clinical Cancer Research

Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical...



Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif  ScienceDirect.com

Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles wit...



Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles with machine learning and DoE-ANN implementation: Optimization, characterization, and in-vitro assessment for the anticancer drug delivery  ScienceDirect.com

Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma i...



Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy  Nature

Mechanism of sorafenib resistance associated with ferroptosis in HCC - Frontiers



Mechanism of sorafenib resistance associated with ferroptosis in HCC  Frontiers

SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glut...



SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase  Nature

New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sin...



New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica  Nature

Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechani...



Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights  Frontiers

Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma - ScienceDirect.com



Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma  ScienceDirect.com

Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and ...



Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model  ScienceDirect.com

Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib r...



Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer  ScienceDirect.com

Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 ex...



Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 expression  Nature

GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition o...



GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis  Nature

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferropto...



YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis  EMBO Press

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellula...



Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma  ScienceDirect.com

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-cont...



Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG  ScienceDirect.com

Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption...



Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α  Nature

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation ...



Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation  Frontiers

3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by dec...



3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by decreasing tumor cell stemness  Nature

Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocell...



Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma  ScienceDirect.com

Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations an...



Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies  Nature

Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneo...



Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors  Frontiers

New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to ...



New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers  ScienceDirect.com

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in ...



Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells  Nature

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma...



Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration  Nature

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ...



Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis  Journal of Experimental & Clinical Cancer Research

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co...



Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors  Nature

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312...



Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial  The Lancet

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo s...



MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling  Nature

MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferro...



MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferroptosis induction  Nature

Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mi...



Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes  ScienceDirect.com

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-...



Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma  Nature

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT...



S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway  ScienceDirect.com

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma | Acta Pha...



Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma | Acta Pharmacologica Sinica  Nature

Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induce...



Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma  Journal of Experimental & Clinical Cancer Research

Sorafenib inhibits ossification of the posterior longitudinal ligament by blocking LOXL2-mediated...



Sorafenib inhibits ossification of the posterior longitudinal ligament by blocking LOXL2-mediated vascularization  Nature

Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma ...



Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells  Nature

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma - Nature



ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma  Nature

UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeosta...



UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma | Signal Transduction and Targeted Therapy  Nature

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis...



Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis  ScienceDirect.com

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplan...



Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption  Frontiers

RETRACTED ARTICLE: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysi...



RETRACTED ARTICLE: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma  Nature